Independent · Reader-Supported · Editorially Reviewed
§ Brand Review · GLP-1 Weight Loss

MEDVi Review

Doctor-guided GLP-1 program with both injectable and tablet options across multiple categories.

Last reviewed July 2026
3 studies cited
Fact-checked 18 July 2026Last updated 15 June 2026From $199 – $399/moEditor Score 4.3 / 5Trustpilot 4.4 · Excellent

Reader-supported, we may earn a commission through links on this site. Rankings are editorially independent. Disclosure · Methodology

Quick Verdict

Doctor-guided GLP-1 program with both injectable and tablet options across multiple categories.

Who it's for: Useful for readers who are needle-averse and want oral GLP-1 as a starting option, or who want one provider relationship to span GLP-1, TRT, women's hormones, and skincare. Less ideal if you want highly specialised, single-category care.

Bottom line: MEDVi's oral GLP-1 option and broad category coverage make it a strong generalist pick. Pricing sits at the high end of the field, so verify the monthly all-in cost against single-category specialists before subscribing.

Compare MEDVi on price, review history, and fit

MEDVi may be a strong fit. Before enrolling, compare its published details with three reviewed alternatives. Some links are compensated; editorial scores are independent.

See 6 alternatives vs MEDVi →
At-a-glance price and public review comparison
ProviderPublished priceTrustpilot
WellMedrFrom $49 – $129/mo4.6/5 (1,963)
TrimiFrom $99 – $125/moNot listed
Direct MedsFrom $249 – $297/mo4.6/5 (14,599)
Pros
  • Oral GLP-1 tablet option for needle-averse patients
  • Doctor-guided protocol on every plan
  • Multi-category coverage in one provider relationship
Cons
  • Higher starting price than several competitors
  • Tablet GLP-1 is newer territory. long-term efficacy data is still developing

Pros & Cons In Detail

Oral GLP-1 tablet option for needle-averse patients
In practice this is one of the differentiators that pushes MEDVi's editor score above the category median.
Doctor-guided protocol on every plan
In practice this is one of the differentiators that pushes MEDVi's editor score above the category median.
Multi-category coverage in one provider relationship
In practice this is one of the differentiators that pushes MEDVi's editor score above the category median.
Higher starting price than several competitors
Cost is in line with category leaders, not below them. readers shopping primarily on monthly out-of-pocket should weigh the alternatives in the listicle.
Tablet GLP-1 is newer territory. long-term efficacy data is still developing
It's a real trade-off worth knowing about before you commit, even if it isn't a deal-breaker on its own.

Compare Before You Choose

Compare MEDVi on price, review history, and program fit.

A positive review is still a reason to compare before enrolling. Some links are compensated; editorial scores are independent.

See 6 alternatives vs MEDVi →
At-a-glance price and public review comparison
ProviderPublished priceTrustpilot
WellMedrFrom $49 – $129/mo4.6/5 (1,963)
TrimiFrom $99 – $125/moNot listed
Direct MedsFrom $249 – $297/mo4.6/5 (14,599)

MEDVi Pricing

Telehealth ads often advertise a low headline price that's the clinic's program fee, not the medication. Here's how the two line items break down at MEDVi.

Program / Membership FeeIncluded in monthly plan
Medication Cost (From)From $199 – $399/mo
What This Means For You

MEDVi bundles physician oversight and shipping into the monthly subscription. Brand-name Wegovy and Zepbound are passed through at clinic-published rates.

Who MEDVi Is For

Useful for readers who are needle-averse and want oral GLP-1 as a starting option, or who want one provider relationship to span GLP-1, TRT, women's hormones, and skincare. Less ideal if you want highly specialised, single-category care.

How MEDVi Markets Itself

Adults who want both injectable and oral GLP-1 options without committing to a single delivery format.

Signature Programs

  • ›Injectable compounded GLP-1
  • ›Oral GLP-1 tablets
  • ›Multi-category men's, women's, and skincare bundles

Medication Formulary

FDA-Approved Access
WegovyZepbound
Full Formulary
compounded semaglutideglp-1 injectionsglp-1 tablets

The Bottom Line

MEDVi's oral GLP-1 option and broad category coverage make it a strong generalist pick. Pricing sits at the high end of the field, so verify the monthly all-in cost against single-category specialists before subscribing.

With an editor score of 4.3 / 5 across cost, experience, and trust, MEDVi is one of the strong mid-tier options in the glp-1 weight loss category we cover.

See how MEDVi compares in our full glp-1 weight loss rankings, or read the Best Telehealth GLP-1 Providers guide. Our methodology explains how we score each provider.

§ FAQ

Frequently Asked Questions

References
  1. Wilding et al., NEJM 2021 (STEP 1) · Semaglutide 2.4 mg produced 14.9% mean weight loss vs 2.4% placebo at 68 weeks in the STEP 1 trial.
  2. FDA Federal Register 2024 (Semaglutide shortage end) · FDA removed semaglutide from the drug shortage list in October 2024, ending the legal basis for compounding.
  3. Garvey et al., NEJM 2022 (STEP 5) · Two-year STEP 5 data confirmed sustained 15.2% weight loss with semaglutide 2.4 mg.

RxNotebook is an editorial publication. Citations point to peer-reviewed journals, FDA labeling, and clinical society guidelines. We are not affiliated with the studies cited above. This page is for general information and is not medical advice.

Alternatives To MEDVi

MEDVi does not currently offer a direct online intake. The providers below offer similar programs and are accepting new patients.

Also Competes With

MEDVi also operates in Peptide Therapy, TRT & Men's Hormones, Women's Health & HRT, Skincare, Hair Loss. Here are other providers in those spaces:

§ Continue Reading